Josh Jennings
Stock Analyst at Morgan Stanley
(1.47)
# 2,378
Out of 4,479 analysts
11
Total ratings
36.36%
Success rate
15.24%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCBO Docebo | Maintains: Overweight | $49 → $53 | $38.06 | +39.25% | 5 | Nov 10, 2023 | |
| PODD Insulet | Maintains: Outperform | $350 → $300 | $196.16 | +52.94% | 3 | Aug 9, 2023 | |
| MDWD MediWound | Initiates: Outperform | n/a | $15.39 | - | 1 | Sep 28, 2017 | |
| CTSO Cytosorbents | Initiates: Outperform | n/a | $0.70 | - | 1 | Jun 7, 2017 | |
| EW Edwards Lifesciences | Maintains: Outperform | n/a | $90.25 | - | 1 | Dec 7, 2016 |
Docebo
Nov 10, 2023
Maintains: Overweight
Price Target: $49 → $53
Current: $38.06
Upside: +39.25%
Insulet
Aug 9, 2023
Maintains: Outperform
Price Target: $350 → $300
Current: $196.16
Upside: +52.94%
MediWound
Sep 28, 2017
Initiates: Outperform
Price Target: n/a
Current: $15.39
Upside: -
Cytosorbents
Jun 7, 2017
Initiates: Outperform
Price Target: n/a
Current: $0.70
Upside: -
Edwards Lifesciences
Dec 7, 2016
Maintains: Outperform
Price Target: n/a
Current: $90.25
Upside: -